Ignite Creation Date:
2024-05-06 @ 7:42 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02589496
Status:
COMPLETED
Last Update Posted:
2023-05-09
First Post:
2015-10-27
Brief Title:
Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine Integration of Molecular Subtypes Through Integrative Genomic Analysis
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-27
First Submit QC Date:
October 27 2015
Study First Post Date:
2015-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-06
Last Update Post Date:
2023-05-09
Last Update Post Date Type:
ACTUAL